Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 26;6(1):30.
doi: 10.3390/jof6010030.

Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast

Affiliations
Review

Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast

Ryan Kean et al. J Fungi (Basel). .

Abstract

Candida auris is an enigmatic yeast that continues to stimulate interest within the mycology community due its rapid and simultaneous emergence of distinct clades. In the last decade, almost 400 manuscripts have contributed to our understanding of this pathogenic yeast. With dynamic epidemiology, elevated resistance levels and an indication of conserved and unique pathogenic traits, it is unsurprising that it continues to cause clinical concern. This mini-review aims to summarise some of the key attributes of his remarkable pathogenic yeast.

Keywords: Candida auris; biofilms; in vivo models; pathogenicity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary of in vivo pathogenicity studies of Candida auris. The virulence of C. auris in comparison to various other Candida spp. has been assessed in a number of different vertebrate and invertebrate systems including Galleria mellonella (A), immunocompetent mice (B), immunocompromised mice (C), Danio rerio (D) and Drosophila melanogaster (E). Figure was created with BioRender.
Figure 2
Figure 2
Host-pathogen interactions of Candida auris. Candida auris evades neutrophil capture via neutrophil extracellular trap (NET) formation. Neutrophils preferentially target Candida albicans in mixed cultures with C. auris (A). Peripheral blood mononuclear cells (PBMCs) fail to induce a potent pro-inflammatory cytokine response against C. auris, whilst Candida tropicalis, Candida guilliermondii and Candida krusei induced production of TNF-α, IL-6 and IL1-β in PBMC co-cultures (B). Human monocyte-derived macrophages were shown to recognize and phagocytose C. auris (C). Anti-Als3p antibodies generated by the NDV-3A vaccine in mice significantly reduced biofilm formation capabilities in C. auris (D) and enhanced opsonophagocytic killing by murine macrophages in vitro (E). Neutropenic mice susceptible to lethal C. auris-disseminated infection were protected following Als3p vaccination. Depletion of macrophages and CD4+ T cells in this model resulted in reduced survival rates in mice, suggestive that these cell subsets play an important role in NDV-3A vaccine-mediated protection (F). Figure was created with BioRender.

References

    1. Lockhart S.R., Etienne K.A., Vallabhaneni S., Farooqi J., Chowdhary A., Govender N.P., Colombo A.L., Calvo B., Cuomo C.A., Desjardins C.A., et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin. Infect. Dis. 2017;64:134–140. doi: 10.1093/cid/ciw691. - DOI - PMC - PubMed
    1. Casadevall A., Kontoyiannis D.P., Robert V. On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds. mBio. 2019;10 doi: 10.1128/mBio.01397-19. - DOI - PMC - PubMed
    1. Forsberg K., Woodworth K., Walters M., Berkow E.L., Jackson B., Chiller T., Vallabhaneni S. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. Med. Mycol. 2019;57:1–12. doi: 10.1093/mmy/myy054. - DOI - PubMed
    1. Satoh K., Makimura K., Hasumi Y., Nishiyama Y., Uchida K., Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol. Immunol. 2009;53:41–44. doi: 10.1111/j.1348-0421.2008.00083.x. - DOI - PubMed
    1. Kim M.N., Shin J.H., Sung H., Lee K., Kim E.C., Ryoo N., Lee J.S., Jung S.I., Park K.H., Kee S.J., et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: Identification, antifungal susceptibility, and clinical features. Clin. Infect. Dis. 2009;48:e57-61. doi: 10.1086/597108. - DOI - PubMed